Reuters logo
BRIEF-Hunan Er-kang Pharmaceutical sees Q3, 9-month net profits down
October 13, 2017 / 12:14 PM / 7 days ago

BRIEF-Hunan Er-kang Pharmaceutical sees Q3, 9-month net profits down

Oct 13 (Reuters) - Hunan Er-kang Pharmaceutical Co Ltd

* Says it sees 9-month net profit down 15-28 percent from 722.6 million yuan ($109.70 million)

* Says it sees Q3 net profit down 2-50 percent y/y

Source text in Chinese: bit.ly/2ylwCNg

Further company coverage: ($1 = 6.5872 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below